Postpartum management of women at increased risk of thrombosis - Results of a Canadian pilot survey

Journal of Rheumatology

Volumn 33, Issue 11, 2006, Pages 2222-2226

  Spitzer, Karen A ^a,c   Murphy, Kellie ^a   Crowther, Mark ^b   Clark, Christine A ^a   Laskin, Carl A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^c TERM Program   (Canada)

Author keywords

Antiphospholipid antibodies; Postpartum; Risk; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT;

ANTIBODY TITER; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CANADA; CESAREAN SECTION; CLINICAL DECISION MAKING; DEEP VEIN THROMBOSIS; FEMALE; FETUS DEATH; FETUS WASTAGE; HUMAN; MEDICAL SPECIALIST; PILOT STUDY; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PUERPERIUM; QUESTIONNAIRE; RECURRENT PREGNANCY LOSS; RISK ASSESSMENT; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TREATMENT PLANNING;

ANTIBODIES, ANTIPHOSPHOLIPID; CANADA; FEMALE; HEALTH CARE SURVEYS; HEPARIN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SPECIALTIES, MEDICAL; THROMBOSIS;

EID: 33750999933     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
2. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-9.
3. Rai R, Cohen H, Dave M, Regan L. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:233-7.
4. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999;54:265-71.
5. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999;42:1309-11.
6. Pettila V, Kaaja R, Leinonen P, Ekhlad U, Kataja M, Iddla E. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy. Thromb Res 1999;96:275-82.
7. Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 1983;62:239-43.
8. Friend JR, Kakkar VV. The diagnosis of deep vein thrombosis in the puerperium. J Obstet Gynaecol Br Commonw 1970;77:820.
9. Henderson SR, Lund DJ, Creasman WT. Antepartum pulmonary embolism. Am J Obstet Gynecol 1972;112:474-86.
10. Aaro LA, Juergens JL. Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol 1971;109:1128-36.
11. Moore JG, O'Leary JA, Johnson PM. The changing impact of pulmonary thromboembolism in obstetrics. Am J Obstet Gynecol 1967;97:507-13.
12. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80:614-20.
13. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GKV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
14. Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med 2000;343:1439-44.
15. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119 Suppl 1:122S-31S.
16. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 2003;101:1333-44.
17. Thromboprophylaxis during pregnancy, labour and after vaginal delivery. London: Royal College of Obstetricians and Gynaecologists 2004; Guideline 37.
18. American College of Obstetricians and Gynecologists Educational Bulletin. 1998;244:151-60.
19. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002;99:135-44.
20. Derksen RHWM, de Grool PG, Nieuwenhuis HK, Christiaens GCML. How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis 2001;60:1-3.
21. Carson SA, Branch DW. Management of recurrent early pregnancy loss. ACOG Practice Bulletin 2001: Number 24.
22. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L, Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low close aspirin and heparin. Br J Obstet Gynaecol 1999;106:102-7.
23. Soloninka CA, Laskin CA, Wither J, Wong D, Bombardier C, Raboud J. Clinical utility and specificity of anticardiolipin antibodies. J Rheumatol 1991;18:1849-55.
24. Galli M. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk? Thromb Res 2004;114:597-601.
25. Aseh DA, J Edrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50:1129-36.